Citadel Investment Advisory’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
Other funds holding ENOV
DC
PMG
RRAM
TCM
BCA
DDPIC
VIM
YIH
WCM
Citadel Investment Advisory's ENOV Position: Q2 2026 in Review
Citadel Investment Advisory sold out of Enovis (ENOV) in Q2 2026, closing a stake of 2,159 shares — an estimated $49K sold.
Citadel Investment Advisory first reported a position in ENOV in Q1 2022 and held it in 17 quarters. The position peaked at $937K in Q2 2022. 57 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.
- Citadel Investment Advisory reported no remaining Enovis position as of Q2 2026 after selling out during the quarter.
- Citadel Investment Advisory sold 2,159 Enovis shares in Q2 2026, an estimated $49K.
- Citadel Investment Advisory first reported a position in Enovis in Q1 2022 and held it in 17 quarters.
- Citadel Investment Advisory's Enovis position peaked at $937K in Q2 2022.
- 57 funds tracked by Wall St. Rank held Enovis as of Q2 2026.
Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.